Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Keryx Biopharmaceuticals Inc (NASDAQ:KERX)

7.72
Delayed Data
As of Jul 29
 -0.37 / -4.57%
Today’s Change
7.29
Today|||52-Week Range
18.48
-45.44%
Year-to-Date

Today’s Trading

Previous close8.09
Today’s open8.30
Day’s range-- - --
Volume1,585,474
Average volume (3 months)1,773,503
Market cap$838.1M
Dividend yield--
Data as of 07/29/2015

Growth & Valuation

Earnings growth (last year)-112.07%
Earnings growth (this year)+23.40%
Earnings growth (next 5 years)+30.00%
Revenue growth (last year)+54.64%
P/E ratioNM
Price/Sales118.95
Price/Book10.20

Competitors

 Today’s
change
Today’s
% change
NXTMNxStage Medical Inc+0.16+1.15%
LXRXLexicon Pharmaceutic...-0.12-1.40%
AMRIAlbany Molecular Res...-0.06-0.29%
SGMOSangamo BioSciences ...-0.29-3.15%
Data as of 07/29/2015

Financials

Next reporting dateAugust 5, 2015
EPS forecast (this quarter)-$0.26
Annual revenue (last year)$10.8M
Annual profit (last year)-$111.5M
Net profit margin-1,030.19%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Gregory P. Madison
Chief Financial Officer
Scott A. Holmes
Corporate headquarters
New York, New York

Forecasts